Funds and ETFs Ampio Pharmaceuticals, Inc.

Equities

AMPE

US03209T3077

Biotechnology & Medical Research

Market Closed - Nyse 04:00:00 2024-03-28 pm EDT 5-day change 1st Jan Change
0.92 USD +12.20% Intraday chart for Ampio Pharmaceuticals, Inc. -45.88% -55.12%
Ampio Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the preclinical development of AR-300, and is conducting studies to evaluate the efficacy of AR-300 in osteoarthritis-related pain. The Company is primarily targeting the clinical development of AR-300 for the treatment of osteoarthritis of the knee (OAK). AR-300 is a small-molecule formulation that has demonstrated anti-inflammatory properties in vitro and protection of cartilage in preclinical rat meniscal tear studies.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
  1. Stock
  2. Equities
  3. Stock Ampio Pharmaceuticals, Inc. - Nyse
  4. Funds and ETFs Ampio Pharmaceuticals, Inc.